Skip to main content
OpenTrials

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,891 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Completed

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

NCT03052751

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Mg0002 712 Los Angeles, California, United States
  • Mg0002 701 Orange, California, United States
  • Mg0002 713 Miami, Florida, United States
  • Mg0002 708 Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

NCT01217437

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 158 locations
View Trial Details
Completed

Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma

NCT00879437

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • Children's Medical Center Dallas, Center for Cancer and Blood Disorders Dallas, Texas, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

NCT02798406

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +24 more
Locations
  • University of Arkansas for Medical Sciences (UAMS) Little Rock, Arkansas, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Minnesota Neurosurgery Minneapolis, Minnesota, United States
View all 15 locations
View Trial Details
Completed

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

NCT02124772

Conditions
Cancer, Hemic and Lymphatic Diseases, Histiocytosis, +23 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
  • Novartis Investigative Site Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Completed

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

NCT00528437

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumors, +18 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Emory University Atlanta, Georgia, United States
  • Hawaii Pacific Health Lihue, Hawaii, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 17 locations
View Trial Details

Related conditions